Brooklyn, NY, United States of America

Susan L Zultanski

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan L Zultanski. Retrieved from https://idiyas.com/inventor/susan-l-zultanski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Cambridge, MA (US) (2012)
  • Brooklyn, NY (US) (2019 - 2023)

Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Susan L. Zultanski

Introduction

Susan L. Zultanski is a notable inventor based in Brooklyn, NY. She has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important compounds. With a total of three patents to her name, her work has had a meaningful impact on medical science.

Latest Patents

One of her latest patents involves processes for the preparation of sugammadex. This invention provides various methods for synthesizing sugammadex from 8-per-deoxy-8-bromo-γ-cyclodextrin and 3-mercaptopropionic acid. Additionally, it outlines alternative processes using disodium 3-mercaptopropionate. Another aspect of her work includes the preparation of 8-per-deoxy-8-bromo-γ-cyclodextrin, which is essential for producing sugammadex. Furthermore, she has developed a process for making chloro-substituted nucleoside phosphoramidate compounds, which are useful in treating and preventing HCV infection.

Career Highlights

Susan L. Zultanski is currently employed at Merck Sharp & Dohme Corporation, where she continues to innovate in the pharmaceutical industry. Her expertise and dedication have led to advancements in drug development and therapeutic solutions.

Collaborations

Throughout her career, Susan has collaborated with esteemed colleagues, including Alan Michael Hyde and Christian Fischer. These partnerships have fostered a collaborative environment that enhances the quality and impact of her work.

Conclusion

Susan L. Zultanski's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to advancing medical science. Her work not only showcases her expertise but also highlights the importance of collaboration in achieving significant breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…